Product Details

Priorix Tetra**

Measles, mumps, and rubella (MMR); Varicella vaccine
0.5 mL
Powder for injection

ROA

Intramuscular; Subcutaneous

Applicant Name

Glaxo Smithkline Consumer Nigeria PLC

NRN

A6-0145

Status

Active


Composition

Measles, Mumps, Rubella and Varicella Vaccine (Live, Attenuated) After reconstitution, 1 dose (0.5 mL) contains: Live attenuated measles virus1 (Schwarz strain) NLT 10(3.0) CCID50(3), Live attenuated mumps virus1 (RIT 4385 strain, derived from Jeryl Lynn strain) NLT 10(4.4) CCID50(3), Live attenuated rubella virus2 (Wistar RA 27/3 strain) NLT 10(3.0) CCID50(3), Live attenuated varicella virus2 (OKA strain) NLT 10(3.3) PFU(4) 1) produced in chick embryo cells 2) produced in human diploid (MRC-5) cells 3) Cell Culture Infective Dose 50% 4) Plaque forming units Excipients: Amino acids, lactose, mannitol, sorbitol. Solvent is water for injections. Neomycin sulphate is present as a residual from the manufacturing process  

ATC Code

 

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

0.5 mL x 1's (in vial)  

Product Description

Powder and solvent for solution for injection. The powder is white to slightly pink. The solvent is clear and colourless

Manufacturer Name

Glaxosmithkline Biologicals S.A

Manufacturer Country

BELGIUM  

Approval Date

2024-02-28  

Expiry Date

2029-02-27